The FDA approved gepotidacin (Blujepa), an oral option for the treatment of uncomplicated urogenital gonorrhea among patients ages 12 years and older, GSK announced on Thursday. "The ability of N.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results